AGP acquires portfolio of products from American pharma firm Viatris

AGP claims newly acquired products will add Rs20b to annual revenues

PPMA vs DRAP: Pharma crisis continues 

Unavailability of medicines could inevitably trigger national health emergency

Pricing dispute causes shortage of critical medicine

Pharma companies stop, limit production of scores of essential and non-essential medicines as govt rejects demand for 38% hike in prices

Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen

WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...

The mechanics behind the panadol shortage

Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on

Where did all the Burnol go?

The household product is missing from pharmacies in Pakistan. But its brand recall still holds

Pharmaceuticals: how the locals are beating the multinationals

In a heavily regulated market, the local players have learned to live with the price rules the way they are, while the foreign players still seem to have hope that things will change

UK report claims Pakistan’s Covid-19 medicine enough for national demand

Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national...

Pharma industry protests govt’s refusal to increase drug prices

LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug...

Pharmaceuticals in Pakistan: extracting whatever they can from the pie

Can the pharmaceutical sector ever be reformed? Kabeer Dawani and Asad Sayeed take a look at the sector’s pitfalls, and ways forward.

Govt takes away drug pricing power from pharmaceutical companies 

ISLAMABAD: The federal government has put an end to the power of pharmaceutical companies to increase prices of drugs while not paying...

Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine

LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...

Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh

Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh. Clarifying its position, the...

Pharmaceuticals may turn to Chinese raw material as tensions with India soar

Pakistan has formulated a strategy to deal with any crisis arising out of an embargo on the import of raw material supplied...

Trump vows to reduce US drug prices to world’s lowest

WASHINGTON: US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to...